Pancreatic cancer presents a formidable challenge in oncology due to its aggressive nature, late diagnosis, and limited treatment options. Conventional therapies have shown limited efficacy against this devastating disease, necessitating innovative approaches to improve patient outcomes. In recent years, nanotechnology has emerged as a promising frontier in pancreatic cancer therapy, offering novel strategies to overcome longstanding challenges. This article explores the dawn of pancreatic cancer therapy and the transformative impact of nanotechnology in surmounting these obstacles. Nanotechnology enables precise targeting of tumor cells, enhanced drug delivery, and improved treatment efficacy through the development of advanced imaging modalities, nanoparticle-based drug delivery systems, and nanosensors for biomarker detection. Despite challenges in optimization and clinical translation, nanotechnology holds immense promise for revolutionizing pancreatic cancer care and improving patient survival rates.
Published Date: 2024-05-31; Received Date: 2024-05-01